Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
A new trend, fueled by social media, involves people taking Ozempic (semaglutide) in tiny doses, a practice dubbed microdosing
Even after retatrutide is approved, Mounjaro will still suit many people because it has a longer real-world safety record, a clearer cardiovascular profile, and produces clinically significant weight loss for most people who tolerate it
The best way to keep moving toward your goals is to partner with a trusted medical team
Final Thoughts Having controlled blood sugar levels should be a goal for everyone, whether youre healthy, prediabetic, or have a diagnosis of type 2 diabetes
Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as nonalcoholic fatty liver disease (NAFLD), has seen its global prevalence surge from 25% between 1990 and 2006 to 38% between 2016 and 2019